Why peptides · why now
Compare Scottsdale providers by verifiable details.
The Phoenix-Scottsdale corridor has been one of the most active anti-aging and longevity medicine markets in the country for nearly two decades. Mayo Clinic Arizona's research presence, the dense concentration of concierge primary-care practices along Camelback and Shea, and a year-round retiree and snowbird population that prioritizes vitality have produced a market that is unusually well-informed about peptide therapy and unusually patient about doing it correctly.
FDA's Pharmacy Compounding Advisory Committee is meeting July 23–24, 2026 to discuss whether BPC-157-, KPV-, TB-500-, and MOTs-C-related bulk drug substances should be included on the 503A Bulks List. The committee provides nonbinding advice; the agenda is not product approval or a blanket authorization for a particular prescription or use. Read the FDA agenda and ask the clinician and pharmacy to explain the current requirements for the exact product under discussion.
For Scottsdale patients, the practical step is to verify the responsible prescriber, exact product, intended use, dispensing pharmacy, evidence, total cost, and follow-up plan before booking.
This directory exists to make those questions easier to ask. We are not affiliated with a clinic, do not sell peptides, and do not recommend a treatment. The national directory is built to help patients compare public information and request a correction when a listing needs one.